PRINCIPIA BIOPHARMA INC's ticker is PRNB and the CUSIP is 74257L108.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $165,000 | +400.0% | 2,763 | +405.1% | 0.01% | +266.7% |
Q1 2020 | $33,000 | -78.6% | 547 | -80.7% | 0.00% | -66.7% |
Q4 2019 | $154,000 | +49.5% | 2,827 | -22.9% | 0.01% | +28.6% |
Q3 2019 | $103,000 | -14.9% | 3,669 | +1.0% | 0.01% | -12.5% |
Q2 2019 | $121,000 | – | 3,632 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
New Leaf Venture Partners, L.L.C. | 1,996,588 | $56,384,000 | 17.05% |
Samsara BioCapital, LLC | 383,480 | $10,829,000 | 7.37% |
Sofinnova Investments, Inc. | 1,417,258 | $40,023,000 | 3.62% |
Cormorant Asset Management, LP | 1,341,896 | $37,895,000 | 2.31% |
Orbimed Advisors | 1,605,713 | $45,345,000 | 0.86% |
Redmile Group, LLC | 790,006 | $22,310,000 | 0.75% |
PFM Health Sciences, LP | 559,553 | $15,802,000 | 0.47% |
RTW INVESTMENTS, LP | 270,948 | $7,652,000 | 0.46% |
Baker Brothers Advisors | 1,654,029 | $46,710,000 | 0.32% |
UNIVERSITY OF NOTRE DAME DU LAC | 24,572 | $694,000 | 0.21% |